ENDO 2021 Top 10 - Clinical Edition
Image For Activity Cover
Credit Offered
No Credit Offered
  • Course Description
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
Exclusively for members, this collection represents the top ENDO 2021 clinical sessions in various topic areas:
  • Thyroid Nodule: Whack It, Zap It, or Leave It Alone?
  • Does the Treatment of Hyperthyroidism Lead to Cancer?
  • Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
  • Closing the Loop With Pump and Sensor Communication in Diabetes Mellitus: How to Digest Data and Develop Treatment Recommendations During a Clinic Visit
  • Complexities in the Diagnosis and Treatment of Cushing Syndrome
  • Clinical Advances in Pituitary Diseases
  • Treating Type 2 Diabetes: New Approaches for an Old Foe
  • Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk
  • Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition
  • When to Stop Imaging in Pituitary Adenomas?

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

To view the full ENDO program and speaker disclosures by session, please visit the program planner.

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

ENDO 2021 virtual meeting received general support from Amgen, Inc.; Concept Therapeutics; Radius Health Inc.; Strongbridge BioPharma; the Leona M. and Harry B. Helmsley Charitable Trust; Ultragenyx Pharmaceutical; Zealand Pharma.

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By